{
  "name": "Clinical and Regulatory Parameters of Therapeutic Intracranial Modalities",
  "description": "Comparative evaluation of intracranial neurosurgical and therapeutic ultrasound modalities compiled from FDA Premarket Approvals, CMS reimbursement schedules, and clinical literature.",
  "page": "https://casrai.org/guides/mr-guided-focused-ultrasound-mrgfus",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-20T19:23:47Z",
  "temporalCoverage": "2024/2026",
  "spatialCoverage": "United States",
  "columns": [
    {
      "name": "Modality",
      "unit": "",
      "description": "Therapeutic or surgical neuromodulatory modality"
    },
    {
      "name": "Invasiveness Level",
      "unit": "",
      "description": "Degree of surgical access and tissue disruption"
    },
    {
      "name": "Primary Mechanism",
      "unit": "",
      "description": "Physical principle delivering clinical effect"
    },
    {
      "name": "Current CPT Billing Code",
      "unit": "",
      "description": "Active AMA Category I coding for procedure reporting"
    },
    {
      "name": "FDA Regulatory Class",
      "unit": "",
      "description": "CDRH medical device risk classification"
    },
    {
      "name": "Adjustability Profile",
      "unit": "",
      "description": "Post-procedural reversibility or parameter adjustment"
    },
    {
      "name": "Standard Hospital Stay",
      "unit": "hours",
      "description": "Typical post-procedure facility observation duration"
    }
  ],
  "rows": [
    {
      "Modality": "MR-Guided Focused Ultrasound (MRgFUS)",
      "Invasiveness Level": "Incisionless (transcranial)",
      "Primary Mechanism": "Convergent acoustic thermal ablation",
      "Current CPT Billing Code": "CPT 61715",
      "FDA Regulatory Class": "Class III (PMA)",
      "Adjustability Profile": "Permanent focal lesion (non-adjustable)",
      "Standard Hospital Stay": 4
    },
    {
      "Modality": "Deep Brain Stimulation (DBS)",
      "Invasiveness Level": "Invasive (burr hole craniotomy & subcutaneous implant)",
      "Primary Mechanism": "High-frequency electrical neuromodulation",
      "Current CPT Billing Code": "CPT 61867",
      "FDA Regulatory Class": "Class III (PMA)",
      "Adjustability Profile": "Programmable and reversible",
      "Standard Hospital Stay": 24
    },
    {
      "Modality": "Stereotactic Radiofrequency Thalamotomy",
      "Invasiveness Level": "Invasive (burr hole probe insertion)",
      "Primary Mechanism": "Electrode thermal coagulative necrosis",
      "Current CPT Billing Code": "CPT 61720",
      "FDA Regulatory Class": "Class II / III (510k/PMA)",
      "Adjustability Profile": "Permanent focal lesion (non-adjustable)",
      "Standard Hospital Stay": 24
    },
    {
      "Modality": "Stereotactic Radiosurgery (Gamma Knife)",
      "Invasiveness Level": "Non-invasive (closed cranial delivery)",
      "Primary Mechanism": "Ionizing gamma radiation focal necrosis",
      "Current CPT Billing Code": "CPT 77371",
      "FDA Regulatory Class": "Class II (510k)",
      "Adjustability Profile": "Delayed permanent lesion (non-adjustable)",
      "Standard Hospital Stay": 4
    }
  ],
  "sources": [
    {
      "title": "FDA Premarket Approval P150038: Exablate Model 4000 System",
      "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150038",
      "accessed": "2026-11-20"
    },
    {
      "title": "Focused Ultrasound Foundation: Technology Overview",
      "url": "https://www.fusfoundation.org/the-technology/",
      "accessed": "2026-11-20"
    },
    {
      "title": "PubMed Central: Focused Ultrasound for Essential Tremor (PMC5425801)",
      "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425801/",
      "accessed": "2026-11-20"
    },
    {
      "title": "PubMed Central: Health Technology Assessment for Essential Tremor (PMC5963668)",
      "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963668/",
      "accessed": "2026-11-20"
    }
  ]
}